| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 04/05/2007 | US20070077232 Conditioned cell culture medium compositions and methods of use |
| 04/05/2007 | US20070077231 Immune effector cells pre-infected with oncolytic virus |
| 04/05/2007 | US20070077230 Method for the pre-conditioning/fixation and treatment of diseases with heat activation/release with thermo-activated drugs and gene products |
| 04/05/2007 | US20070077229 Nucleic acid molecule comprising a nucleic acid sequence which codes for a haemocyanin |
| 04/05/2007 | US20070077228 Method of treating or retarding the development of blindness |
| 04/05/2007 | US20070077227 Preparing DNA binding protein comprising multiple zinc finger domains for use in identifying modulators of protein-nucleic acid recognition; gene expression inhibition |
| 04/05/2007 | US20070077226 Gutless adenovirus vector and the construction method thereof |
| 04/05/2007 | US20070077224 Regulation of T cell-mediated immunity by tryptophan |
| 04/05/2007 | CA2624138A1 Method and composition for increasing the engraftment efficiency of stem cells |
| 04/05/2007 | CA2623957A1 Compositions for and methods of granzyme b inhibition |
| 04/05/2007 | CA2623387A1 Use of ephrinb2 directed agents for the treatment or prevention of viral infections |
| 04/05/2007 | CA2623357A1 Inhibitors of ste20-like kinase (slk) and methods of modulating cell cycle progression and cell motility |
| 04/05/2007 | CA2623239A1 Solid polymer delivery compositions and methods for use thereof |
| 04/04/2007 | EP1770168A2 Compositions and methods for delivery of genetic material |
| 04/04/2007 | EP1770164A2 Streptococcus pneumoniae antigens and vaccines |
| 04/04/2007 | EP1770100A2 Transferrin receptor genes of Moraxella |
| 04/04/2007 | EP1769802A1 NFκB ACTION INHIBITOR AND ANTIINFLAMMATORY AGENT, AND STEROID ACTION FORTIFIER |
| 04/04/2007 | EP1768999A2 B7-dc binding antibody |
| 04/04/2007 | EP1768998A2 Single-stranded and double-stranded oligonucleotides comprising a 2-arylpropyl moiety |
| 04/04/2007 | EP1768703A1 mRNA MIXTURE FOR VACCINATING AGAINST TUMORAL DISEASES |
| 04/04/2007 | EP1768702A2 Preventing arrhythmias associated with cell transplantation |
| 04/04/2007 | EP1383447A4 Stent-based delivery of statins to prevent restenosis |
| 04/04/2007 | EP1352056B1 Polypeptides capable of eliciting an immune reaction against cancer |
| 04/04/2007 | EP1054988B1 Anti-viral vectors |
| 04/04/2007 | CN1942588A Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 04/04/2007 | CN1942583A Optimized expression of HPV 58 L1 in yeast |
| 04/04/2007 | CN1942581A Antibody with osteoclast-related protein as target |
| 04/04/2007 | CN1942201A Methods of modulating cytokine activity; related reagents |
| 04/04/2007 | CN1940076A Conditionally replicating viral vectors and their use |
| 04/04/2007 | CN1940074A Construction, screen and use for stomach cancer target AFP gene siRNAs expression carrier |
| 04/04/2007 | CN1940069A Ig light chain variable region sequence and CDR3 sequence from human cancers and their use |
| 04/04/2007 | CN1940068A Novel receptor nucleic acids and polypeptides |
| 04/04/2007 | CN1940066A Production of expression vermis kinase tr-gene plant and its products |
| 04/04/2007 | CN1939541A Immunostimulatory nucleic acids |
| 04/04/2007 | CN1939538A Use of osteopontin for the treatment and/or prevention of neurologic diseases |
| 04/04/2007 | CN1308451C Tumor necrosis factor related ligand |
| 04/04/2007 | CN1308450C Methods and compositions for diagnosis and treatment of cancer |
| 04/04/2007 | CN1307999C Mixed-cell gene therapy |
| 04/03/2007 | US7199234 Nucleotide sequences coding telomerase reverse transcriptase (TRT) for diagnosing and treating cancers; antiproliferative agents |
| 04/03/2007 | US7199232 Isolated nucleic acid molecules encoding a bacterial uracil transport protein and a bacterial uracil phosphoribosyl-transferase enzyme, cells transformed therewith and uses thereof |
| 04/03/2007 | US7199229 Comprises serine protease for diagnosis, prognosis and treatment of cell proliferative disorders |
| 04/03/2007 | US7199225 Stimulating differentiation in growth of osteoblasts and osteoclasts; wound healing of bone fractures and de novo bone formation; osteoporosis; bone cancer treatment; polynucleotide encoding polypeptide; genetic engineering |
| 04/03/2007 | US7199218 ICBP90 polypeptide and its fragments and polynucleotides coding for said polypeptides and applications for diagnosing and treating cancer |
| 04/03/2007 | US7199109 Potent inhibition of influenza virus by specifically designed short interfering RNA |
| 04/03/2007 | US7199107 Inhibiting synthesis and function; arresting cellular proliferation |
| 04/03/2007 | US7198951 Viral expression vector for use as heterologous gene and/or therapeutic protein delivery tools; genetic vaccine |
| 04/03/2007 | US7198950 Self-inactivating plasmid/vector; gene therapy; treating hematological disorders; anticarcinogenic agents |
| 04/03/2007 | US7198949 Compositions and methods for altering the biodistribution of biological agents |
| 04/03/2007 | US7198944 for the treatment of leukemia, tumors, chronic infections, autoimmune disease, fibrotic disorders, wound healing and psoriasis |
| 04/03/2007 | US7198934 Genetic engineering; gene insertion; culture product |
| 04/03/2007 | US7198929 Nucleotide sequences coding eukaryotic initiation factor-2 kinase for use in the identification of modulators which prevent and treat viral and liver disorders |
| 04/03/2007 | US7198910 Nucleic acid encoding melanin-concentrating hormone receptor |
| 04/03/2007 | US7198909 Myeloid precursor cell useful for gene therapy and for modulation of immune responses |
| 04/03/2007 | US7198793 Bovine immunodeficiency virus (BIV) based vectors |
| 04/03/2007 | US7198792 Alphaviral vector system comprising papilloma viral orgin of replication and antitumor agent for prevention and treatment urogenital cancer; gene therapy |
| 04/03/2007 | US7198790 Growth differentiation factor-5 |
| 04/03/2007 | US7198788 Administering pharmaceutical formulation comprising an anti-CD26 antibody, whereby the anti- CD26 antibody binds CD26 and arrests cell cycle for therapy of cancer |
| 04/03/2007 | US7198784 Retroviral vectors |
| 04/03/2007 | CA2328447C Adeno-associated virus vectors and uses thereof |
| 04/03/2007 | CA2311602C Cell-specific retroviral vectors with antibody domains and method for the production thereof for selective gene transfer |
| 04/03/2007 | CA2276459C Novel method for testing the differentiation status in pancreatic cells of a mammal |
| 04/03/2007 | CA2238295C Complementary adenoviral vector systems and cell lines |
| 04/03/2007 | CA2193365C Polynucleotide vaccine for papillomavirus |
| 04/03/2007 | CA2162397C Ligands for flt3 receptors |
| 03/29/2007 | WO2007035962A2 Gene blocking method |
| 03/29/2007 | WO2007035922A2 Aptamers to the human il-12 cytokine family and their use as autoimmune disease therapeutics |
| 03/29/2007 | WO2007035712A2 Isolation of smooth muscle cells and tissue-engineered vasculature containing the isolated cells |
| 03/29/2007 | WO2007035451A2 Methods of modulating angiogenesis and screening compounds for activity in modulating angiogenesis |
| 03/29/2007 | WO2007034977A1 METHOD OF ESTIMATING AND IDENTIFYING TARGET mRNA CONTROLLED BY FUNCTIONAL RNA AND METHOD OF USING THE SAME |
| 03/29/2007 | WO2007034753A1 Remedy for angiogenesis-related disease comprising chondromodulin-i as the active ingredient |
| 03/29/2007 | WO2007034262A1 Heterodimeric meganucleases and use thereof |
| 03/29/2007 | WO2007033475A1 THE USE OF siRNAs IN ORGAN STORAGE/REPERFUSION SOLUTIONS |
| 03/29/2007 | WO2006128100A3 Chondrogenic compositions and methods of use |
| 03/29/2007 | WO2006086454A3 Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms |
| 03/29/2007 | WO2006055635A3 Compositions and methods for altering wnt autocrine signaling |
| 03/29/2007 | WO2004043399A3 Methods and compositions for inducing immune responses and protective immunity by priming with alphavirus replicon vaccines |
| 03/29/2007 | US20070074300 Sialidase inhibitors for the treatment of cardiovascular disease |
| 03/29/2007 | US20070074295 Schizophrenia related gene |
| 03/29/2007 | US20070073264 Methods, compositions and apparatus for delivering heterologous molecules to cells |
| 03/29/2007 | US20070073047 Genes overexpressed by ovarian cancer and their use in developing novel therapeutics |
| 03/29/2007 | US20070072823 siRNA targeting survivin |
| 03/29/2007 | US20070072822 STAT3 agonists and antagonists and therapeutic uses thereof |
| 03/29/2007 | US20070072820 Gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening |
| 03/29/2007 | US20070072819 Gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening |
| 03/29/2007 | US20070072818 Endothelial growth factors; antiischemic agents; neovascularization |
| 03/29/2007 | US20070072817 Methods for reducing blood pressure |
| 03/29/2007 | US20070072816 Methods for inhibiting angiogenesis |
| 03/29/2007 | US20070072815 Methods and kits to increase the efficiency of oligonucleotide-directed nucleic acid sequence alteration |
| 03/29/2007 | US20070072798 Method for treatment of cardiovascular and metabolic diseases and detecting the risk of the same |
| 03/29/2007 | US20070072796 Oligonucleotide analogues incorporating 5-aza-cytosine therein |
| 03/29/2007 | US20070072794 Novel genes and proteins encoded thereby |
| 03/29/2007 | US20070072296 C/EBPalpha gene targeting constructs and uses thereof |
| 03/29/2007 | US20070072260 Mixture comprising serum complement system protein (INSP163) use in preparation of vaccines and antibodies for treatment and prevention of infection, cell proliferative, skin, neurodegenerative, bone, inflammatory, respiratory system and autoimmune disorders |
| 03/29/2007 | US20070072236 Novel type II Na/Pi cotransporters and type II Na/Pi cotransporter expression regulatory factors |
| 03/29/2007 | US20070072218 A polynucleotide encoding a polypeptide having the amino acid sequence of SEQ ID NO:1, sequence operably linked to a heterologous promoter selected from hsp68, SV40, CMV, GAL4UAS, HSV and beta -actin; anticarcinogenic agents |
| 03/29/2007 | US20070072177 Rabies virus G protein specific immunoglobulin for use in prevention and treatment of viral infections |
| 03/29/2007 | US20070072171 Solid surface for biomolecule delivery and high-throughput assay |
| 03/29/2007 | US20070071823 complexing amphoteric polymers with polynucleotides and delivering the complex into cells |
| 03/29/2007 | US20070071776 Recombinant Vaccine Against Fish Infectious Diseases |
| 03/29/2007 | US20070071770 Recombinant MVA virus, and the use thereof |